散布 发表于 2025-3-25 06:46:55

Submitted on: 10 March 2002.
Revised on: 30 April 2002.
Accepted on: 17 June 2002.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

Biguanides 发表于 2025-3-25 11:11:42

Submitted on: 12 November 2003.
Revised on: 23 January 2004.
Accepted on: 19 February 2004.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

蛤肉 发表于 2025-3-25 15:36:17

Submitted on: 12 March 2020.
Revised on: 19 June 2020.
Accepted on: 07 July 2020.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

Cirrhosis 发表于 2025-3-25 19:49:26

Submitted on: 11 February 2012.
Revised on: 18 April 2012.
Accepted on: 19 May 2012.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

Vldl379 发表于 2025-3-25 20:55:09

http://reply.papertrans.cn/1/48/4784/4784-25.png

异端邪说下 发表于 2025-3-26 04:13:19

Submitted on: 01 January 2025.
Revised on: 23 February 2025.
Accepted on: 27 March 2025.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

有组织 发表于 2025-3-26 08:09:45

Submitted on: 26 August 2013.
Revised on: 26 October 2013.
Accepted on: 20 December 2013.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

anus928 发表于 2025-3-26 12:11:28

Submitted on: 15 January 2005.
Revised on: 02 March 2005.
Accepted on: 14 March 2005.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

tolerance 发表于 2025-3-26 16:30:48

Submitted on: 11 July 2022.
Revised on: 27 October 2022.
Accepted on: 06 November 2022.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC

起皱纹 发表于 2025-3-26 16:56:38

Submitted on: 27 June 1998.
Revised on: 03 October 1998.
Accepted on: 16 November 1998.

___________________CARDIOVASCULAR PATHOLOGY---ELSEVIER SCIENCE INC
页: 1 2 [3] 4
查看完整版本: SCIE期刊CARDIOVASCULAR PATHOLOGY 2024/2025影响因子:2.356 (CARDIOVASC PATHOL) (1054-8807). (CARDIAC & CARDIOVASCULAR SYSTEMS)(